Oral IL-23 inhibitor promising for treatment of moderate-to-severe plaque psoriasis: NEJM Medha Baranwal9 Feb 2024 10:00 AM ISTCanada: A recent study showed greater treatment efficacy with the interleukin-23-receptor antagonist peptide JNJ-77242113 after 16 weeks of once- or...
Experimental topical PDE4 inhibitor showed superior efficacy for atopic dermatitis, plaque psoriasis: JAMA Medha Baranwal12 Jan 2024 6:30 AM ISTUSA: A phase 2a study published in JAMA Dermatology revealed the superior efficacy of an experimental topical phosphodiesterase 4 (PDE4) inhibitor to...
Sun Pharma Ilumetri now included in category B of China National Reimbursement Drug List Ruchika Sharma14 Dec 2023 2:43 PM ISTILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
FDA approved Bimzelx for plaque psoriasis now commercially available Dr. Kamal Kant Kohli15 Nov 2023 7:15 PM ISTIn October US Food and Drug Administration had approved for plaque psoriasis. Bimzelx, an IL-17A and IL-17F inhibitor is now commercially available...
Bristol Myers Squibb Sotyktu long term data demonstrate durable efficacy, consistent safety for up to 3 years in moderate-to-severe Plaque Psoriasis Ruchika Sharma12 Oct 2023 12:50 PM ISTPrinceton: Bristol Myers Squibb has announced new three-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu...
Prove efficacy of Itolizumab for subcutaneous route: CDSCO panel Tells Biocon Biologics Dr. Divya Colin13 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Biocon...
Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
Tildrakizumab linked to improved outcomes in plaque psoriasis patients Jacinthlyn Sylvia10 July 2023 9:30 AM ISTAlmirall, a global biopharmaceutical company specializing in medical dermatology, has announced significant progress in the treatment of...
Aurobindo Pharma arm CuraTeQ Biologics to commercialize proposed biosimilar to Stelara Ruchika Sharma8 July 2023 12:00 PM ISTCuraTeQ intends to file this product in India and Emerging Markets as early as in 2024 and the regulated markets filing is expected to begin in 2026.
Janssen reports positive results from phase 2b FRONTIER 1 trial of JNJ-2113 in plaque psoriasis patients Ruchika Sharma6 July 2023 2:30 PM ISTJNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with...
Calcipotriol and Calcitriol combo with UV phototherapy effective in Chronic Stable Plaque Psoriasis Dr. Kamal Kant Kohli26 Jun 2023 8:00 PM ISTA recent study published in the journal Photodermatology, Photoimmunology & Photomedicine has demonstrated that the combination therapy of vitamin...
Brodalumab effective in treating Plaque psoriasis, reports study Niveditha Subramani18 Jun 2023 8:00 PM ISTBrodalumab is a monoclonal antibody approved by the United States Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in...
